Shanghai Fosun Pharma files HKEX next-day return disclosing H-share buyback at HKD 16.53

PUBT · 1d ago
Shanghai Fosun Pharma files HKEX next-day return disclosing H-share buyback at HKD 16.53
  • Shanghai Fosun Pharmaceutical repurchased 217,000 H shares on Aug. 27, 2026 for HKD 3.59 million.
  • Buyback price range HKD 16.45 to HKD 16.59 per share; weighted average HKD 16.53.
  • All repurchased shares were held as treasury shares; cancelled shares: 0.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Fosun Pharmaceutical (Group) Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260827-12302163), on August 27, 2026, and is solely responsible for the information contained therein.